Gene expression study of host-human T-cell leukaemia virus type 1 (HTLV-1) interactions: adult T-cell leukaemia/lymphoma (ATLL)
- PMID: 37480512
- DOI: 10.1007/s11033-023-08626-8
Gene expression study of host-human T-cell leukaemia virus type 1 (HTLV-1) interactions: adult T-cell leukaemia/lymphoma (ATLL)
Abstract
Background: In HTLV-1-associated malignant disease, adult T-cell leukaemia/lymphoma (ATLL), the interaction of virus and host was evaluated at the chemokines gene expression level. Also, IL-1β and Caspase-1 expressions were evaluated to investigate the importance of pyroptosis in disease development and progression.
Methods and results: The expression of host CCR6 and CXCR-3 and the HTLV-1 proviral load (PVL), Tax, and HBZ were assessed in 17 HTLV-1 asymptomatic carriers (ACs) and 12 ATLL patients using the reverse transcription-quantitative polymerase chain reaction (RT-qPCR), TaqMan method. Moreover, RT-qPCR, SYBR Green assay were performed to measure Caspase-1 and IL-1β expression. HTLV-1-Tax did not express in 91.5% of the ATLLs, while HBZ was expressed in all ATLLs. The expression of CXCR3 dramatically decreased in ATLLs compared to ACs (p = 0.001). The expression of CCR6 was lower in ATLLs than ACs (p = 0.04). The mean of PVL in ATLL patients was statistically higher than ACs (p = 0.001). Furthermore, the expression of the IL-1β between ATLLs and ACs was not statistically significant (p = 0.4). In contrast, there was a meaningful difference between Caspase-1 in ATLLs and ACs (p = 0.02).
Conclusions: The present study indicated that in the first stage of ATLL malignancy toward acute lymphomatous, CXCR3 and its progression phase may target the pyroptosis process. Mainly, HBZ expression could be a novel therapeutic target.
Keywords: ATLL; CXCR3; HBZ; HTLV-1; Pyroptosis; Tax.
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
References
-
- Gessain A, Cassar O (2012) Epidemiological aspects and World distribution of HTLV-1 infection. Front Microbiol 3:388. https://doi.org/10.3389/fmicb.2012.00388 - DOI - PubMed - PMC
-
- Ahmadi Ghezeldasht S, Shirdel A, Assarehzadegan MA, Hassannia T, Rahimi H, Miri R et al (2013) Human T lymphotropic virus type I (HTLV-I) oncogenesis: molecular aspects of virus and host interactions in pathogenesis of adult T cell Leukemia/Lymphoma (ATL). Iran J Basic Med Sci 16(3):179–195 - PubMed - PMC
-
- Mota TM, Jones RB (2019) HTLV-1 as a model for virus and host coordinated immunoediting. Front Immunol 10:2259. https://doi.org/10.3389/fimmu.2019.02259 - DOI - PubMed - PMC
-
- Lemoine FJ, Wycuff DR, Marriott SJ (2001) Transcriptional activity of HTLV-I Tax influences the expression of marker genes associated with cellular transformation. Dis Markers 17(3):129–137. https://doi.org/10.1155/2001/263567 - DOI - PubMed
-
- Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K et al (2009) In vivo, expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology 6:19. https://doi.org/10.1186/1742-4690-6-19 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
